Abstract
Factor V leiden G1691A/R506Q (FVL), prothrombin G20210A (FII) and methylenetetrahydrofolate reductase (MTHFR) C677T are related genetic risk factors for venous thromboembolism. Analysis for those mutations is increasingly being performed on patients exhibiting hypercoagulability. The objective of this study was to determine the prevalence of FVL, FII-G20210A and MTHFR-C677T polymorphisms and their coexistence among apparently healthy Palestinians. After institutional approval, 303 apparently healthy students from An-Najah University representative to North and South regions of West Bank with no previous history of cardiovascular diseases participated in this study. A uniform questionnaire was used to collect relevant information through personal interview with the subjects. The collected information included gender, age, smoking habits, weight and height, diseases such as diabetes, cardiovascular and family history of CVD. The frequencies of allelic distribution of the three prothrombotic polymorphisms factor V G1691A/R506Q), prothrombin G2010A, and MTHFR-C677T were 0.114, 0.050 and 0.071, respectively. The prevalence of the three thrombotic polymorphisms (FVL, FII G20210A and MTHFR-C677T) were 20.1, 9.1 and 13.8 %, respectively. Statistical analysis for factor V leiden showed no significant association between place of residence (P value = 0.953) and gender (P value >0.082). The data presented in this study showed the highest prevalence of FVL among healthy Palestinians compared to other populations and this important finding should be followed in terms of clinical significance.
Similar content being viewed by others
References
Dahlbäck B (2008) Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood 112(1):19–27
Walker JD (2000) Thrombophilia in pregnancy. J Clin Pathol 53(8):570–573
Bertina RM, Koeleman BP, Koster T et al (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64–67
Finan R, Tamim H, Ameen G et al (2002) Prevalence of factor VG1691A (factor V-leiden) and prothrombin gene mutations in a recurrent miscarriage population. Am J Hematol 71:300–305
Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV, Bozzo M, Mannucci PM (2000) Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 343(14):1015–1018
Isotalo PA, Wells GA, Donnelly JG (2000) Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. Am J Hum Genet 67(4):986–990
Lensen R, Rosendaal F, Vandenbroucke J, Bertina R (2000) Factor V leiden: the venous thrombotic risk in thrombophilic families. Br J Haematol 110(4):939–945
Kist WJ, Janssen NG, Kalk JJ, Hague WM, Dekker GA, de Vries JL (2008) Thrombophilias and adverse pregnancy outcome—a confounded problem. Thromb Haemostat 99(1):77–85
Dahlbäck B (1997) Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management. Semin Hematol 34(3):217–234
Khan S, Dickerman JD (2006) Hereditary thrombophilia Thromb J 4:15
Rees DC, Cox M, Clegg JB (1995) World distribution of factor V leiden. Lancet 346(8983):1133–1134
Koksal V, Baris I, Etlik O (2007) Primer-engineered multiplex PCR-RFLP for detection of MTHFR C677T, prothrombin G20210A and factor V Leiden mutations. Exp Mol Pathol 83(1):1–3
Husseini A, Abu-Rmeileh NM, Mikki N, Ramahi TM, Ghosh HA, Barghuthi N, Khalili M, Bjertness E, Holmboe-Ottesen G, Jervell J (2009) Cardiovascular diseases, diabetes mellitus, and cancer in the occupied Palestinian territory. Lancet 373(9668):1041–1049
Hussein AS, Darwish H, Shelbayeh K (2010) Association between factor V leiden mutation and poor pregnancy outcomes among Palestinian women. Thromb Res 126(2):e78–82
Bathelier C, Champenois T, Lucotte G (1998) ARMS test for diagnosis of factor V leiden mutation and allele frequencies in France. Mol Cell Probes 12:121–123
Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88(10):3698–3703
Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10(1):111–113
Kark JD, Fink R, Adler B, Goldberger N, Goldman S (2006) The incidence of coronary heart disease among Palestinians and Israelis in Jerusalem. Int J Epidemiol 35(2):448–457
Cleary-Goldman J, Nakhuda GS, Zimmermann RC, Sauer MV (2003) The role of factor V leiden mutation in recurrent pregnancy loss. J Am Med Womens Assoc 58(3):165–172
Ozmen F, Ozmen MM, Ozalp N, Akar N (2009) The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis. Ulus Travma Acil Cerrahi Derg 15(2):113–119
Dashti AA, Jadaon MM, Abdulsamad AM, Dashti MH, Lewis HL (2011) Thrombosis risk in carriers of the factor V leiden mutation: is it associated with a defined skin color? Pathol Res Pract 207(11):671–673
Almawi WY, Keleshian SH, Borgi L, Fawaz NA, Abboud N, Mtiraoui N, Mahjoub T (2005) Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs. J Thromb Thrombolysis 20(3):163–168
Dashti AA, Jadaon MM (2011) Race differences in the prevalence of the factor V leiden mutation in Kuwaiti nationals. Mol Biol Rep 38(6):3623–3628
Eid SS, Rihani G (2004) Prevalence of factor V leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians. Clin Lab Sci 17(4):200–202
Nusier MK, Radaideh AM, Ababneh NA, Qaqish BM, Alzoubi R, Khader Y, Mersa JY, Irshaid NM, El-Khateeb M (2007) Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians. Neuro Endocrinol Lett 28(5):699–703
Rosen E, Renbaum P, Heyd J, Levy-Lahad E (1999) High frequency of factor V leiden in a population of Israeli Arabs. Thromb Haemostat 82(6):1768
Settin A, Dowaidar M, El-Baz R, Abd-Al-Samad A, El-Sayed I, Nasr M (2008) Frequency of factor V leiden mutation in Egyptian cases with myocardial infarction. Hematology 13(3):170–174
Akar N, Misirlioğlu M, Akar E, Avcu F, Yalçin A, Sözüöz A (1998) Prothrombin gene 20210 G-A mutation in the Turkish population. Am J Hematol 58(3):249
Almawi WY, Finan RR, Tamim H, Daccache JL, Irani-Hakime N (2004) Differences in the frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene among the Lebanese population. Am J Hematol 76(1):85–87
Acknowledgment
We would like to thank Ms Alaa Darwish for her help in this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hussein, A.S. High prevalence of three prothrombotic polymorphisms among Palestinians: factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase C677T. J Thromb Thrombolysis 34, 383–387 (2012). https://doi.org/10.1007/s11239-012-0731-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-012-0731-9